<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03260387</url>
  </required_header>
  <id_info>
    <org_study_id>R01DK109124</org_study_id>
    <nct_id>NCT03260387</nct_id>
  </id_info>
  <brief_title>A Prospective Observational Study of TPIAT</brief_title>
  <acronym>POST</acronym>
  <official_title>Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT (POST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baylor Health Care System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center, prospective, observational cohort study of patients undergoing total
      pancreatectomy with islet autotransplantation (TPIAT)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who are undergoing TPIAT at one of the participating center are invited to
      participate in this observational study, with 450 participants anticipated. The aims of the
      study are:

      Aim 1: To determine (1a) whether patient and disease characteristics are associated with
      favorable pain and health-related quality-of-life outcomes (HRQOL) after TPIAT; (1b) the
      optimal timing of the TPIAT intervention to resolve pain and improve HRQOL; and (1c) in a
      subset of patients, the impact of central sensitization on pain resolution.

      Aim 2: To determine (2a) whether patient and disease characteristics are associated with
      favorable glycemic outcomes from the IAT procedure; and (2b) the optimal timing of TPIAT to
      obtain post-surgical insulin independence.

      Aim 3: To determine the cost-effectiveness of TPIAT.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Reduction</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Visual Analog Pain Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Physical Component Summary Score from SF-12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Mental Component Summary Score from SF-12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetes</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Proportion of patients insulin independent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>proportion off opioid analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Morphine Equivalents (avg daily ME)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic Control</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>HbA1c level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin Dose</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Insulin Dose (U/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Islet Graft Function</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Proportion with Islet Graft Function (C-peptide + or Off Insulin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe Hypoglycemia Episodes</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Proportion of patients with Severe Hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>Mos 6, Years 1, 2, 3, 4 after surgery</time_frame>
    <description>Pain interference Score (PROMIS scale)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Pancreatitis, Chronic</condition>
  <condition>Pancreatectomy; Hyperglycemia</condition>
  <condition>Pancreatitis</condition>
  <arm_group>
    <arm_group_label>TPIAT</arm_group_label>
    <description>patients undergoing total pancreatectomy with islet autotransplant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TPIAT</intervention_name>
    <description>The entire pancreas is removed to treat the pain of chronic pancreatitis, and the islets are infused back into the patient to reduce diabetes risk after surgery.</description>
    <arm_group_label>TPIAT</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Optional (opt in) biorepository samples:

        1. Blood (plasma, serum, buffy coat)

        2. Urine

        3. Saliva

        4. Pancreas biopsy at time of surgery
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children and Adults undergoing TPIAT for severe pancreatitis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Any patient with chronic or recurrent acute pancreatitis undergoing total or completion
        pancreatectomy with islet autotransplantation at a participating center.

        Exclusion Criteria:

          1. Partial pancreatectomy

          2. TPIAT performed for a diagnosis other than chronic or recurrent acute pancreatitis
             (for example benign or malignant pancreatic tumor)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melena Bellin, MD</last_name>
    <phone>612-625-4686</phone>
    <email>bell0130@umn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Basto</last_name>
      <phone>773-702-2504</phone>
      <email>Lindsay.basto@uchospitals.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lesley Hightower Crane</last_name>
      <phone>410-614-6708</phone>
      <email>lhighto1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Ptacek</last_name>
      <phone>612-626-5905</phone>
      <email>vorwa001@umn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Chevalier</last_name>
      <phone>603-653-9033</phone>
      <email>jessica.i.chevalier@hitchcock.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Misty Troutt</last_name>
      <phone>513-803-1971</phone>
      <email>Misty.troutt@cchmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey McClurkin</last_name>
      <phone>614-688-9575</phone>
      <email>Casey.McClurkin@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Fedorek</last_name>
      <phone>412-692-2207</phone>
      <email>fedoreksp@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mortadha Abd</last_name>
      <phone>843-792-8824</phone>
      <email>abdm@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Elizabeth Farrow</last_name>
      <phone>214-820-1822</phone>
      <email>Anne.Farrow@BSWHealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2017</study_first_posted>
  <last_update_submitted>August 21, 2017</last_update_submitted>
  <last_update_submitted_qc>August 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

